Haptoglobin Genotypes Associated with Vaso-Occlusive Crisis in Sickle Cell Anemia Patients of Eastern India

Abstract Sickle cell anemia is hallmarked by hemolysis, which releases hemoglobin (Hb) into the plasma promoting vaso-occlusive crisis (VOC). Haptoglobin (Hp) clears free Hb and decreases Hb-related pathophysiology in sickle cell anemia. There are two alleles (HP1 and HP2) and three genotypes (HP1-1, HP1-2 and HP2-2) of Hp with different frequencies in different populations. This study involved Hp level and genotype among normal and sickle cell anemia patients with varying severity of VOC. A total of 297 sickle cell anemia patients and 98 healthy controls were selected for the study. The sickle cell anemia patients were categorized as ‘mild-phenotype’ with no pain episodes and ‘severe-phenotype’ as having three or more acute pain episodes in the preceding 12 months. The Hp level was significantly lower (p < 0.001) in sickle cell patients anemia than controls; HP1-1 genotype had a higher Hp level compared to HP1-2 and HP2-2 (p < 0.05). Turkey-Kramer multiple comparison tests showed that mild and severe phenotypes have significant differences (p < 0.05) in Hb F%, Hb, platelet count, aspartate aminotransferase (AST), alanine aminotransferase (ALT), direct-bilirubin (Bil-D), total-bilirubin (Bil-T), lactate dehydrogenase (LDH) and Hp level. Pearson correlation revealed that Hp level has a positive (p < 0.05) correlation with Hb F%, Hb, packed cell volume (PCV) and serum urea; in contrast its level is negatively correlated with AST, ALT, Bil-T and LDH. A significantly higher frequency of HP2 allele and HP2-2 genotypes was found in severe phenotypes. In the studied population, it was found that higher HP2 frequency, low Hp level and more hemolysis favors the onset of VOC in sickle cell anemia.

[1]  M. DeBaun,et al.  Haptoglobin genotype predicts severe acute vaso‐occlusive pain episodes in children with sickle cell anemia , 2020, American journal of hematology.

[2]  S. Saad,et al.  Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patients , 2019, Annals of Hematology.

[3]  P. Das,et al.  Association of plasma homocysteine level with vaso-occlusive crisis in sickle cell anemia patients of Odisha, India , 2019, Annals of Hematology.

[4]  P. Das,et al.  Erythrocyte cAMP in Determining Frequency of Acute Pain Episodes in Sickle Cell Disease Patients from Odisha State, India , 2019, Hemoglobin.

[5]  M. Gladwin,et al.  Intravascular hemolysis and the pathophysiology of sickle cell disease , 2017, The Journal of clinical investigation.

[6]  G. Vercellotti,et al.  Serum Haptoglobin and Hemopexin Levels in Pediatric SS and SC Disease Patients: Biomarker of Hemolysis and Inflammation , 2016 .

[7]  V. Gordeuk,et al.  Platelets decline during Vaso‐occlusive crisis as a predictor of acute chest syndrome in sickle cell disease , 2015, American journal of hematology.

[8]  S. Thein,et al.  Super‐elevated LDH and thrombocytopenia are markers of a severe subtype of vaso‐occlusive crisis in sickle cell disease , 2015, American journal of hematology.

[9]  I. Hambleton,et al.  Intravenous infusion of haptoglobin for the prevention of adverse clinical outcome in Sickle Cell Disease. , 2015, Medical hypotheses.

[10]  Hillel W. Cohen,et al.  Elevated Steady State WBC and Platelet Counts Are Associated with Frequent Emergency Room Use in Adults with Sickle Cell Anemia , 2015, PloS one.

[11]  P. Purohit,et al.  Prevalence of Deletional Alpha Thalassemia and Sickle Gene in a Tribal Dominated Malaria Endemic Area of Eastern India , 2014, ISRN hematology.

[12]  Janet S. Lee,et al.  Nitric Oxide Scavenging by Red Blood Cell Microparticles and Cell-Free Hemoglobin as a Mechanism for the Red Cell Storage Lesion , 2011, Circulation.

[13]  B. Das,et al.  Higher fetal hemoglobin concentration in patients with sickle cell disease in eastern India reduces frequency of painful crisis , 2009, European journal of haematology.

[14]  S. Mao,et al.  Unique Assembly Structure Of Human Haptoglobin Phenotypes 1-1, 2-1, And 2-2 And A Predominant Hp1 Allele Hypothesis , 2009 .

[15]  S. Leal,et al.  Deviations from Hardy-Weinberg Equilibrium in Parental and Unaffected Sibling Genotype Data , 2008, Human Heredity.

[16]  V. Fuster,et al.  Haptoglobin Genotype Is a Determinant of Iron , Lipid Peroxidation , and Macrophage Accumulation in the Atherosclerotic Plaque , 2006 .

[17]  Joan Valls,et al.  SNPStats: a web tool for the analysis of association studies , 2006, Bioinform..

[18]  A. Kastrati,et al.  Haptoglobin gene subtyping by restriction enzyme analysis. , 2003, Clinical chemistry.

[19]  A. Kastrati,et al.  Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR. , 2002, Clinical chemistry.

[20]  R. Recker,et al.  Population admixture: detection by Hardy-Weinberg test and its quantitative effects on linkage-disequilibrium methods for localizing genes underlying complex traits. , 2001, Genetics.

[21]  S. Moestrup,et al.  Identification of the haemoglobin scavenger receptor , 2001, Nature.

[22]  J. Delanghe,et al.  Biological and clinical significance of haptoglobin polymorphism in humans. , 1996, Clinical chemistry.

[23]  M. Adedoyin,et al.  Hepatic function tests in children with sickle cell anaemia during vaso occlusive crisis. , 1994, The Central African journal of medicine.

[24]  D. Mason,et al.  A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily , 1993, European journal of immunology.

[25]  A. Bandopadhaya,et al.  Haptoglobin subtypes in a Bengalee population sample. , 1992, Anthropologischer Anzeiger; Bericht uber die biologisch-anthropologische Literatur.

[26]  A. Kulozik,et al.  Two different forms of homozygous sickle cell disease occur in Saudi Arabia , 1991, British journal of haematology.

[27]  J. Raynes,et al.  Acute‐phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin‐1 and interleukin‐6 , 1991, Clinical and experimental immunology.

[28]  R. Cortese,et al.  Structure and expression of the human haptoglobin locus. , 1985, The EMBO journal.

[29]  F. Yang,et al.  Identification and characterization of human haptoglobin cDNA. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Talukder,et al.  Haptoglobin types in cancer patients in comparison with normal populations in the Eastern India. , 1976, Gan.

[31]  C. Cockerham,et al.  VARIANCE OF GENE FREQUENCIES , 1969, Evolution; international journal of organic evolution.

[32]  C. Cockerham.  Group inbreeding and coancestry. , 1967, Genetics.

[33]  R. Aster.  Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. , 1966, The Journal of clinical investigation.

[34]  R. N. Shukla,et al.  Sickle cell disease in India. , 1958, Blood.

[35]  M. Jayle,et al.  [Chemical constitution and electrophoresis of haptoglobin]. , 1950, Comptes rendus des seances de la Societe de biologie et de ses filiales.

[36]  ��� S������i.  gene analysis. , 2010 .

[37]  R. Voegeli,et al.  A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. , 1987, Experimental cell biology.

[38]  R. Deka,et al.  Investigations on the variability of haptoglobin, transferrin and Gc polymorphisms in Assam, India. , 1986, Human heredity.

[39]  J. Westwick,et al.  Platelet activation during steady state sickle cell disease. , 1983, Journal of medicine.

[40]  S. Das,et al.  The haptoglobin and transferrin types in West Bengal and a case of haptoglobin 'Johnson'. , 1970, Human heredity.